Blog | HemaCare

Point-of-Care Device May Improve Outcomes for Patients with Critical Limb Ischemia

Dec 21, 2016 12:00:16 AM / by Stacy Matthews Branch, DVM, PhD posted in Bone marrow, cd 34 stem cells, Critical Limb Ischemia, Point of care device, research, stem cell research

0 Comments

Researchers use bone marrow provided by HemaCare to help patients with critical limb ischemia.

Critical limb ischemia (CLI) is a condition caused by blocked arteries leading to low blood flow to the legs, feet, and other extremities. This causes severe pain, skin sores, gangrene, and can also lead to death. Amputation is often needed due to a lack of effective treatment options for CLI. The poor outcomes for patients with CLI have stimulated research efforts to find effective treatments such as autologous cell therapies. A new approach to treatment that is being investigated involves using cells from bone marrow aspirate supplied by HemaCare (bone marrow collected with a needle and syringe).

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts